{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15705341",
  "DateCompleted": {
    "Year": "2005",
    "Month": "04",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1080-6040",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "1",
        "PubDate": {
          "Year": "2005",
          "Month": "Jan"
        }
      },
      "Title": "Emerging infectious diseases",
      "ISOAbbreviation": "Emerg Infect Dis"
    },
    "ArticleTitle": "Distribution and characteristics of Escherichia coli clonal group A.",
    "Pagination": {
      "StartPage": "141",
      "EndPage": "145",
      "MedlinePgn": "141-5"
    },
    "Abstract": {
      "AbstractText": [
        "Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim-sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Infectious Diseases (111F), Minneapolis VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA. johns007@umn.edu"
          }
        ],
        "LastName": "Johnson",
        "ForeName": "James R",
        "Initials": "JR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Murray",
        "ForeName": "Andrew C",
        "Initials": "AC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kuskowski",
        "ForeName": "Michael A",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Schubert",
        "ForeName": "S\u00f6ren",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pr\u00e8re",
        "ForeName": "Marie-Francoise",
        "Initials": "MF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Picard",
        "ForeName": "Bertrand",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Colodner",
        "ForeName": "Raul",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Raz",
        "ForeName": "Raul",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "CollectiveName": "Trans-Global Initiative for Antimicrobial Resistance Initiative (TIARA) Investigators"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, Non-P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Emerg Infect Dis",
    "NlmUniqueID": "9508155",
    "ISSNLinking": "1080-6040"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "8064-90-2",
      "NameOfSubstance": "Trimethoprim, Sulfamethoxazole Drug Combination"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [
        "epidemiology",
        "microbiology"
      ],
      "DescriptorName": "Communicable Diseases, Emerging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Bacterial"
    },
    {
      "QualifierName": [
        "classification",
        "drug effects",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "Escherichia coli"
    },
    {
      "QualifierName": [
        "epidemiology",
        "microbiology"
      ],
      "DescriptorName": "Escherichia coli Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Phylogeny"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prevalence"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Trimethoprim, Sulfamethoxazole Drug Combination"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "United States"
    },
    {
      "QualifierName": [
        "epidemiology",
        "microbiology"
      ],
      "DescriptorName": "Urinary Tract Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virulence"
    }
  ]
}